Dnyandev G Gadhave
Overview
Explore the profile of Dnyandev G Gadhave including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kulkarni N, Chauhan G, Quadros M, Gadhave D, Gupta V
Pharm Res
. 2024 Dec;
41(12):2331-2345.
PMID: 39633081
Objective: Malignant pleural mesothelioma (MPM) is the most prevalent subtype of malignant mesothelioma that affects the pleural lining of the lungs. Conventionally, chemotherapy via systemic injections has shown limited efficacy...
2.
Gadhave D, Sugandhi V, Jha S, Nangare S, Gupta G, Singh S, et al.
Ageing Res Rev
. 2024 Jun;
99:102357.
PMID: 38830548
Neurodegenerative disorders (NDs) are expected to pose a significant challenge for both medicine and public health in the upcoming years due to global demographic changes. NDs are mainly represented by...
3.
Gadhave D, Quadros M, Ugale A, Goyal M, Ayehunie S, Gupta V
Int J Biol Macromol
. 2024 Apr;
267(Pt 2):131491.
PMID: 38599435
Quetiapine hemifumarate (QF) delivery to the CNS via conventional formulations is challenging due to poor solubility and lower oral bioavailability (9 %). Similarly, many other second-generation antipsychotics, such as olanzapine,...
4.
Gadhave D, Sugandhi V, Sarvepalli S, Kokare C
Brain Res
. 2024 Mar;
1832:148808.
PMID: 38490145
No abstract available.
5.
Gadhave D, Sugandhi V, Kokare C
Brain Res
. 2023 Nov;
1822:148674.
PMID: 37952871
The tight junction of endothelial cells in the central nervous system (CNS) has an ideal characteristic, acting as a biological barrier that can securely regulate the movement of molecules in...
6.
Gadhave D, Kokare C
Drug Dev Ind Pharm
. 2019 Feb;
45(5):839-851.
PMID: 30702966
Background: Multiple sclerosis (MS) is one of the most severe autoimmune disorder of the central nervous system (CNS). Objective: The present research work was aimed to formulate and investigate teriflunomide...
7.
Gadhave D, Tagalpallewar A, Kokare C
AAPS PharmSciTech
. 2019 Jan;
20(1):22.
PMID: 30604305
Potential risk of agranulocytosis is one of the drug-induced adverse effects of the second-generation antipsychotic agents. The present investigation aimed to formulate and investigate olanzapine (OLZ)-loaded nanostructured lipid carriers (OLZ-NLCs)...